Scarica l'app Stockscreener
230.40
0.65%
1.48
Dopo l'orario di chiusura:
230.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$228.92
Aprire:
$228.81
Volume 24 ore:
2.34M
Relative Volume:
0.61
Capitalizzazione di mercato:
$162.74B
Reddito:
$24.27B
Utile/perdita netta:
$3.50B
Rapporto P/E:
47.42
EPS:
4.8589
Flusso di cassa netto:
$5.02B
1 W Prestazione:
+0.03%
1M Prestazione:
+1.68%
6M Prestazione:
+13.78%
1 anno Prestazione:
+0.26%
Intervallo 1D:
$227.23
$232.10
Intervallo di 1 settimana:
$227.23
$232.10
Portata 52W:
$171.00
$258.23
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Confronta DHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
230.40 | 161.70B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
592.51 | 217.70B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
669.99 | 54.02B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
137.95 | 38.58B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
225.37 | 38.39B | 15.90B | 1.28B | 2.21B | 7.2842 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - FinancialContent
Single-Use Bioprocessing Products Market Set to Reach USD 36 - openPR.com
Vanderbilt University Takes Position in Danaher Corporation $DHR - MarketBeat
Allspring Global Investments Holdings LLC Raises Stock Holdings in Danaher Corporation $DHR - MarketBeat
Fortive Corp.: The Quiet Infrastructure Platform Powering the Next Industrial Upgrade - AD HOC NEWS
Danaher stock in focus: defensive quality meets cautious optimism as Wall Street updates its targets - AD HOC NEWS
Strength in Medical & Fluid Solutions Unit Drives Nordson: Can It Sustain? - TradingView — Track All Markets
Meridian Financial Partners LLC Takes $896,000 Position in Danaher Corporation $DHR - MarketBeat
Calamos Wealth Management LLC Has $16.98 Million Stake in Danaher Corporation $DHR - MarketBeat
Calamos Advisors LLC Sells 36,163 Shares of Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To Follow NowDecember 28th - MarketBeat
The Truth About Danaher Corp: Hidden Giant Every Investor Keeps Sleeping On - AD HOC NEWS
Biotech Stocks To ConsiderDecember 27th - MarketBeat
Simplify Asset Management Inc. Sells 10,166 Shares of Danaher Corporation $DHR - MarketBeat
Mirova US LLC Cuts Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Stock in Focus: Subtle Pullback, Strong Underlying Story - AD HOC NEWS
Cwm LLC Acquires 10,580 Shares of Danaher Corporation $DHR - MarketBeat
Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings - ts2.tech
Danaher (NYSE:DHR) Stock Little Changed in Life Sciences Sector - Kalkine Media
Danaher Corporation $DHR Position Increased by HM Payson & Co. - MarketBeat
Norris Perne & French LLP MI Has $15.08 Million Stake in Danaher Corporation $DHR - MarketBeat
Ethic Inc. Lowers Position in Danaher Corporation $DHR - MarketBeat
Biotech Stocks To Keep An Eye OnDecember 25th - MarketBeat
Manitou Investment Management Ltd. Sells 12,572 Shares of Danaher Corporation $DHR - MarketBeat
Baker Chad R Decreases Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Purchased by Exchange Traded Concepts LLC - MarketBeat
P/E Ratio Insights for Danaher - Benzinga
How Fresh Analyst Optimism On Bioprocessing At Danaher (DHR) Has Changed Its Investment Story - simplywall.st
Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open - ts2.tech
HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
Ex-Dividend Reminder: Medtronic, Danaher and DENTSPLY SIRONA - Nasdaq
James Hambro & Partners LLP Lowers Stock Holdings in Danaher Corporation $DHR - MarketBeat
Swedbank AB Reduces Stock Position in Danaher Corporation $DHR - MarketBeat
DAVENPORT & Co LLC Has $133.51 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Best Biotech Stocks Worth WatchingDecember 18th - MarketBeat
Riverbridge Partners LLC Has $49.61 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
CCLA Investment Management Increases Holdings in Danaher Corporation $DHR - MarketBeat
Assenagon Asset Management S.A. Increases Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR is Arthur M. Cohen & Associates LLC's 6th Largest Position - MarketBeat
Zacks Research Has Strong Estimate for Danaher Q4 Earnings - MarketBeat
Goldman Sachs and KeyBanc are Bullish on Danaher (DHR) - Finviz
2025-12-21 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Danaher Corporation (DHR) and Encourages Shareholders to Learn More About the Investigation | NYSE:DHR | Press Release - Stockhouse
Goldman Sachs and KeyBanc are bullish on Danaher (DHR) - MSN
Foster Victor Wealth Advisors LLC Has $19.71 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Holdings Lowered by CHICAGO TRUST Co NA - MarketBeat
Douglas Lane & Associates LLC Acquires 73,352 Shares of Danaher Corporation $DHR - MarketBeat
Danaher (DHR): Revisiting Valuation as Earnings Grow While the Share Price Stalls - simplywall.st
Promising Biotech Stocks To Watch NowDecember 14th - MarketBeat
Danaher (NYSE:DHR) shareholders have endured a 0.9% loss from investing in the stock three years ago - Yahoo Finance
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.25%
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):